Dafna Gladman, MD

Dr. Gladman is Professor of Medicine at the University of Toronto, and Senior Scientist at the Krembil Research Institute and Schroeder Arthritis Institute. She is Deputy Director of the Centre for Prognosis Studies in The Rheumatic Diseases, Director, Psoriatic Arthritis Program, University Health Network and co‐Director of the University of Toronto Lupus Clinic. Dr. Gladman’s research focuses on psoriatic arthritis (PsA) and systemic lupus erythematosus with emphasis on database development, prognosis studies, genetic markers, assessment instruments, and quality of life measures.  The Toronto PsA Clinic was established in 1978 and is the largest PsA longitudinal cohort in the world.   Dr. Gladman’s laboratory research program involves genetic and biomarkers studies of PsA making this a truly translational research program.

Gladman authored 2 books, edited 3 books, and has  over 900 peer‐reviewed publications, 141 chapters and invited publications and over 1250 published abstracts. Dr. Gladman established the International Psoriasis and Arthritis Research Team (IPART) and is Past‐President of the international Group for Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), a Co – PI of the SpondyloARthritis Research Consortium of Canada (SPARCC).  

Dr. Gladman has received numerous awards in including the Verna Wright Prize for outstanding contribution to the field of Psoriatic Arthritis, the Carol Nachman Prize for outstanding research activities in the field of rheumatology and the American College of Rheumatology Clinician Investigator award.  Dr. Gladman is a Master of the American College of Rheumatology and the Canadian Rheumatology Association, and she has been elected to the Canadian Academy of Science and SigmaFi.